China Diagnostic Reagent Industry Report, 2010
  • Oct/2010
  • Hard Copy
  • USD $1,100
  • Pages:43
  • Single User License
    (PDF Unprintable)       
  • USD $1,200
  • Code: YF007
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,800
  • Hard Copy + Single User License
  • USD $1,300
In 2009, China’s diagnostic reagent market represented about 5% of the global market, and Chinese enterprises still concentrated on low-end biochemistry diagnostic reagent market.

In China, there had been more than 70 biochemistry diagnostic reagent producers by the end of 2009, with sales over RMB 4 billion in total. At present, there are only about a dozen of immune diagnostic reagent producers with sales of RMB 1.5 billion in total, and there are no more than five nucleic acid diagnostic reagent producers with the market size of no more than RMB 500 million in all. By contrast, in foreign markets, the share of biochemistry diagnostic reagent has become very low, while immune diagnostic reagent and nucleic acid diagnostic reagent featuring higher detection sensitivity and specificity have become the mainstream.

The major diagnostic reagent producers in China include KHB and Da An Gene, all of which hold certain market shares by virtue of their own technology strength. Da An Gene mainly produces nucleic acid diagnostic reagent which can compete with the international advanced level in technology and quality. In 2009, Da An Gene’s nucleic acid diagnostic reagent business accounted for over 50% of the company’s operating income and about 60% of the domestic nucleic acid diagnostic reagent market. In addition, with the launch of China nucleic acid blood screening market, the nucleic acid blood screening business is expected to become a new profit point of Da An Gene.

Operating Income and YoY Growth of Nucleic Acid Diagnostic Reagent Sector of Da An Gene, 2006-2009
Source: Announcement of Da An Gene; ResearchInChina
1. Industry Profile 
1.1 Definition and Classification
1.2 Industrial Chain
1.2.1Upstream Market 
1.2.2 Downstream Market 

2. Operating Environment in China
2.1 Global Market 
2.1.1 Development of Biopharmaceutical Industry Worldwide
2.1.2 Development of Diagnostic Reagent Industry Worldwide
2.2 Chinese Market
2.2.1 Development of Biopharmaceutical Industry in China
2.2.2 Relevant Policies of China

3. Development in China
3.1 Overview 
3.2 Import & Export
3.3 Market Segments
3.3.1 Biochemistry Diagnostic Reagent 
3.3.2 Immune Diagnostic Reagent 
3.3.3 Nucleic Acid Diagnostic Reagent 
3.4 Development Tendency of Diagnostic Reagent Sector in China

4. Domestic Major Producers
4.1 KHB
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Operation of Diagnostic Reagent Business
4.2 Da An Gene
4.2.1 Profile
4.2.2 Operation
4.2.3 Operation of Diagnostic Reagent Business
4.3 Fosun Pharmaceutical (Group)
4.3.1 Profile
4.3.2 Operation
4.4 Biosino Bio-Technology & Science Inc 
4.4.1 Profile
4.4.2 Operation
4.5 Zhuhai Livzon Diagnostics
4.5.1 Profile
4.5.2 Operation
4.6 ACON Laboratories
4.6.1 Profile
4.6.2 Operation
4.7 Beijing Wantai Biological Pharmacy
4.7.1 Profile
4.7.2 Operation
4.8 Shanghai Rongsheng Biotech
4.8.1 Profile
4.8.2 Operation
4.9 Beijing Chemclin Biotech
4.9.1 Profile
4.9.2 Operation
4.10 PG Biotech
4.10.1 Profile
4.10.2 Major Products
4.11 Kinghawk Pharmaceutical 
4.11.1 Profile
4.11.2 Operation
4.12 ABON Biopharm (Hangzhou)
4.12.1 Profile
4.12.2 Operation
4.13 Shanghai Upper Bio-Tech Pharma
4.13.1 Profile
4.13.2 Operation
4.14 Beijing Leadman Biochemical
4.14.1 Profile
4.14.2 Operation
4.15 Blue Cross Bio-Medical (Beijing)
4.15.1 Profile
4.15.2 Operation
4.16 Inverness Medical (Shanghai)
4.16.1 Profile
4.16.2 Operation
4.17 Baso Diagnostics
4.17.1 Profile
4.17.2 Operation
4.18 Beijing North Institute of Biological Technology
4.18.1 Profile
4.18.2 Operation
4.19 DiaSys Diagnostic Systems (Shanghai)
4.19.1 Profile
4.19.2 Operation
4.20 Other Enterprises
4.20.1 Autobio
4.20.2 Biobase
4.20.3 Boson Biotechnology
Global Biopharmaceutical Market Scale and YoY Growth, 2000-2009
Global Biopharmaceutical Revenue by Region, 2008
Mergers and Acquisitions of Global Diagnostic Reagent Industry, Jan.2007-Jan.2010 
Sales and Proportion of In-Vitro Diagnostic Reagents of Major European Countries, 2008 
China’s Biopharmaceutical Sales and YoY Growth, 2005-2009
Relevant Polices of Diagnostic Reagent Industry in China
Major Diagnostic Reagent Producers in China
Composition of In-Vitro Diagnostic Reagents in China, 2009
Import Value of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients, Jan.-Aug., 2010
Export Value of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients, Jan.-Aug., 2010
China’s Biochemical Reagent Market Scale and Growth Rate, 2007-2010
China’s Immune Reagent Market Scale and YOY Growth, 2007-2013
Operating Income and Net Profit of KHB, 2006-2010Q1
Operating Income of KHB by Product, 2007-2009
Sales Revenue of Diagnostic Reagent of KHB by Product, 2007-2009
Revenue from Blood Screening Business of KHB,2011 E
Operating Income and Net Profit of Da An Gene, 2006-2010 Q1
Operating Income of Da An Gene by Product, 2007-2009
Operating Income and YOY Growth of Nucleic Acid Diagnostic Reagent of Da An Gene, 2006-2009
Revenue from Blood Screening Business of Da An Gene, 2011
Operating Income and Net Profit of Fosun Pharmaceutical (Group), 2006-2010 H1
Operating Income and Net Profit of Biosino Bio-Technology & Science, 2006-2010 H1
Operating Income of Zhuhai Livzon Diagnostics, 2007-2009
Major Products of Zhuhai Livzon Diagnostics
Operating Income and Gross Profit of ACON, 2007-2008
Operating Income and Gross Profit of Beijing Wantai Biological Pharmacy, 2007-2008
Operating Income and Gross Profit of Shanghai Rongsheng Biotech, 2007-2008
Operating Income and Gross Profit of Beijing Chemclin Biotech, 2007-2008
Detection Reagent of PG Biotech
Operating Income and Net Profit of Kinghawk Pharmaceutical, 2008-2010 H1
Operating Income of Kinghawk Pharmaceutical by Product, 2008-2009
Operating Income and Gross Profit of ABON Biopharm (Hangzhou), 2007-2008
Operating Income and Gross Profit of Shanghai Upper Bio-Tech Pharma, 2007-2008
Operating Income and Gross Profit of Beijing Leadman Biochemical, 2007-2008
Operating Income and Gross Profit of Blue Cross Bio-Medical (Beijing), 2007-2008
Revenue and Gross Profit of Inverness Medical (Shanghai), 2007-2008
Operating Income and Gross Profit of Baso Diagnostics, 2008
Operating Income and Gross Profit of Beijing North Institute of Biological Technology, 2007-2008
Operating Income and Gross Profit of DiaSys Diagnostic Systems (Shanghai), 2007-2008

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号